Private Advisor Group LLC grew its holdings in HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 288.4% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 11,730 shares of the company’s stock after acquiring an additional 8,710 shares during the quarter. Private Advisor Group LLC’s holdings in HCA Healthcare were worth $3,510,000 at the end of the most recent reporting period.
Several other large investors also recently modified their holdings of HCA. Covestor Ltd grew its holdings in shares of HCA Healthcare by 122.7% during the first quarter. Covestor Ltd now owns 167 shares of the company’s stock worth $42,000 after buying an additional 92 shares in the last quarter. Fortis Capital Advisors LLC acquired a new position in HCA Healthcare during the fourth quarter valued at approximately $48,000. BDO Wealth Advisors LLC boosted its position in HCA Healthcare by 60.0% during the second quarter. BDO Wealth Advisors LLC now owns 160 shares of the company’s stock valued at $49,000 after purchasing an additional 60 shares during the last quarter. Cutler Group LLC CA boosted its position in HCA Healthcare by 566.7% during the first quarter. Cutler Group LLC CA now owns 200 shares of the company’s stock valued at $52,000 after purchasing an additional 170 shares during the last quarter. Finally, WASHINGTON TRUST Co boosted its position in HCA Healthcare by 100.0% during the second quarter. WASHINGTON TRUST Co now owns 180 shares of the company’s stock valued at $55,000 after purchasing an additional 90 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of analysts have recently issued reports on HCA shares. Mizuho cut their price objective on HCA Healthcare from $325.00 to $275.00 and set a “buy” rating for the company in a research report on Wednesday, October 25th. Oppenheimer raised their price objective on HCA Healthcare from $310.00 to $315.00 and gave the company an “outperform” rating in a research report on Friday, July 28th. Royal Bank of Canada lowered their target price on HCA Healthcare from $315.00 to $284.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 25th. Sanford C. Bernstein lowered their target price on HCA Healthcare from $345.00 to $294.00 in a research note on Tuesday, October 10th. Finally, Citigroup lowered their target price on HCA Healthcare from $324.00 to $279.00 and set a “buy” rating on the stock in a research note on Wednesday, October 25th. Two investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $296.59.
HCA Healthcare Trading Up 0.8 %
NYSE HCA opened at $248.41 on Tuesday. The company has a quick ratio of 0.99, a current ratio of 1.15 and a debt-to-equity ratio of 103.06. HCA Healthcare, Inc. has a twelve month low of $215.96 and a twelve month high of $304.86. The company has a market cap of $66.49 billion, a price-to-earnings ratio of 12.22, a price-to-earnings-growth ratio of 1.38 and a beta of 1.66. The business’s fifty day moving average is $241.84 and its 200 day moving average is $266.21.
HCA Healthcare (NYSE:HCA – Get Free Report) last released its quarterly earnings data on Tuesday, October 24th. The company reported $3.91 earnings per share for the quarter, missing the consensus estimate of $3.97 by ($0.06). The firm had revenue of $16.21 billion for the quarter, compared to analyst estimates of $15.77 billion. HCA Healthcare had a net margin of 9.05% and a return on equity of 2,040.32%. As a group, sell-side analysts expect that HCA Healthcare, Inc. will post 18.18 EPS for the current fiscal year.
HCA Healthcare Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Thursday, December 28th. Shareholders of record on Thursday, December 14th will be issued a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a yield of 0.97%. The ex-dividend date is Wednesday, December 13th. HCA Healthcare’s payout ratio is presently 11.81%.
HCA Healthcare Company Profile
HCA Healthcare, Inc, through its subsidiaries, provides health care services in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Featured Stories
- Five stocks we like better than HCA Healthcare
- Are Penny Stocks a Good Fit for Your Portfolio?
- Safeguard your portfolio with these three bargain stocks
- Dividend Capture Strategy: What You Need to Know
- Membership clubs gain leverage for the consumer rebound
- The 3 Best Blue-Chip Stocks to Buy Now
- Advanced Auto Parts may be worth more in pieces than the whole
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.